Proteinea
Proteinea is a biotechnology company specializing in the rational engineering of antibody Fc domains using proprietary AI models and computational tools. Their platform enables the design of next-generation antibodies with enhanced efficacy, safety, and convenience by tuning immune function, improving half-life, and targeting biodistribution. Proteinea integrates manufacturability, stability, pharmacokinetics, and delivery considerations into their modular Fc scaffolds to reduce downstream failure and accelerate therapeutic development. Their approach combines AI-driven prediction with lean experimental validation to efficiently translate computational designs into biological reality, positioning them as innovators in biologics engineering for life-threatening diseases.
Proteinea
Proteinea is a biotechnology company specializing in the rational engineering of antibody Fc domains using proprietary AI models and computational tools. Their platform enables the design of next-generation antibodies with enhanced efficacy, safety, and convenience by tuning immune function, improving half-life, and targeting biodistribution. Proteinea integrates manufacturability, stability, pharmacokinetics, and delivery considerations into their modular Fc scaffolds to reduce downstream failure and accelerate therapeutic development. Their approach combines AI-driven prediction with lean experimental validation to efficiently translate computational designs into biological reality, positioning them as innovators in biologics engineering for life-threatening diseases.
TL;DR
Headquarters: Cambridge / Boston, MA
Founded: 2020
Core focus: AI-driven antibody Fc and protein engineering
Total disclosed funding: USD 7,490,000
Notable technologies: RaGene (AI gene/codon optimization)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Biologics engineering—designing next-generation antibodies and sequence optimization to improve therapeutic properties and manufacturability.
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
USD 4,700,000
USD 2,200,000
USD 500,000
USD 90,000
Investor Signal
“500 Global; Core Vision Investments; Den Venture Capital; ICLUB VC; IndieBio; Jedar Capital; SOSV; Sadu Capital; Sawari Ventures; Shorooq Partners; Sukna Ventures; TA Ventures; UI Investments”